Direction, evidence grade, and study type are AI-generated labels (gpt-5-mini), not human-verified. Syntheses are LLM-written. "Tensions" are machine-detected candidates, not confirmed contradictions. A research-acceleration tool, not peer review.
How this is built →
1Distinct papers
5Unique collaborators
1/1OpenAlex citation coverage
Publication dates unavailable. Corpus fetch span: 2026.
Identity provenance
Provider IDs
- Openalex:
A5010708245
ORCID evidence
No valid ORCID is stored.
Observed aliases (1)
- Anmol Suresh Suryavanshi (openalex, provider refresh)
Topics and outcomes in this view
Assessment themes
- Governance: 1 paper
- Innovation: 1 paper
- Productivity: 1 paper
Claim outcomes
- Governance And Regulation: 1 paper
- Market Structure: 1 paper
- Organizational Efficiency: 1 paper
- Other: 1 paper
- Research Productivity: 1 paper
- Adoption Rate: 1 paper
- Ai Safety And Ethics: 1 paper
- Decision Quality: 1 paper
- Firm Revenue: 1 paper
- Innovation Output: 1 paper
- Regulatory Compliance: 1 paper
Papers in the OpenAlex view
Latest stored OpenAlex author observations only. Citation counts below are from the same provider and are not combined with other services.
Scroll the table horizontally to see every column.
| Paper | Author evidence | Date | Provider citations |
|---|---|---|---|
| Decentralized Autonomous Organizations can mobilize tokenized capital and community governance to accelerate early-stage drug discovery, but regulatory uncertainty, health-data privacy and token-market incentives threaten long-run effectiveness and patient protection.semantic_scholar | Anmol Suresh Suryavanshi provider id |
Fetched 2026-03-18 | 0 |
Citation observation summary
OpenAlex supplied counts for 1 of 1 papers in this view; 0 are missing. The observed paper counts sum to 0 cumulative citations. This is a coverage summary, not an author score or h-index.